45 found
Sort by:
  1. Valery M. Gordon, Jeremy Sugarman & Nancy Kass (forthcoming). Toward a More Comprehensive Approach to Protecting Human Subjects: The Interface of Data Safety Monitoring Boards and Institutional Review Boards in Randomized Clinical Trials. Irb.
    No categories
    Direct download  
     
    My bibliography  
     
    Export citation  
  2. Jeremy Sugarman, Nancy E. Kass, Steven N. Goodman, Patricia Perentesis, Praveen Fernandes & Ruth R. Faden (forthcoming). What Patients Say About Medical Research. Irb.
    No categories
    Direct download  
     
    My bibliography  
     
    Export citation  
  3. Ubaka Ogbogu, Sarah Burningham, Adam Ollenberger, Kathryn Calder, Li Du, Khaled El Emam, Robyn Hyde-Lay, Rosario Isasi, Yann Joly, Ian Kerr, Bradley Malin, Michael McDonald, Steven Penney, Gayle Piat, Denis-Claude Roy, Jeremy Sugarman, Suzanne Vercauteren, Griet Verhenneman, Lori West & Timothy Caulfield (2014). Policy Recommendations for Addressing Privacy Challenges Associated with Cell-Based Research and Interventions. BMC Medical Ethics 15 (1):7.
    The increased use of human biological material for cell-based research and clinical interventions poses risks to the privacy of patients and donors, including the possibility of re-identification of individuals from anonymized cell lines and associated genetic data. These risks will increase as technologies and databases used for re-identification become affordable and more sophisticated. Policies that require ongoing linkage of cell lines to donors’ clinical information for research and regulatory purposes, and existing practices that limit research participants’ ability to control what (...)
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  4. Bridget Haire, Morenike Oluwatoyin Folayan, Catherine Hankins, Jeremy Sugarman, Sheena McCormack, Gita Ramjee & Mitchell Warren (2013). Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials: Examining PrEP. Developing World Bioethics 13 (2):87-94.
    The successful demonstration that antiretroviral (ARV) drugs can be used in diverse ways to reduce HIV acquisition or transmission risks – either taken as pre-exposure prophylaxis (PrEP) by those who are uninfected or as early treatment for prevention (T4P) by those living with HIV – expands the armamentarium of existing HIV prevention tools. These findings have implications for the design of future HIV prevention research trials. With the advent of multiple effective HIV prevention tools, discussions about the ethics and the (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  5. Jeremy Sugarman (2012). Questions Concerning the Clinical Translation of Cell-Based Interventions Under an Innovation Pathway. Journal of Law, Medicine and Ethics 40 (4):945-950.
    Stem cell-based innovation is one pathway to clinical translation that stands in contrast to clinical research and medical treatment. After reviewing recently issued guidelines for responsible innovation, this article examines the potential benefits and harms of using this pathway as well as practical barriers and conceptual concerns regarding it.
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  6. John A. Crump & Jeremy Sugarman (2011). Guidelines for International Service Learning Programs. Developing World Bioethics 11 (3):170-170.
    Direct download (9 more)  
     
    My bibliography  
     
    Export citation  
  7. Jeremy Sugarman, Dale E. Hammerschmidt, Christine Grady, Lisa Eckenwiler, Carol Levine & Alan Fleischman (2011). Dealing With the Long-Term Social Implications of Research. American Journal of Bioethics 11 (5):5-9.
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  8. Stuart Rennie & Jeremy Sugarman (2010). Developing Ethics Guidance for HIV Prevention Research: The HIV Prevention Trials Network Approach. Journal of Medical Ethics 36 (12):810-815.
    More than 25 years into the HIV epidemic, in excess of 2 million new infections continue to occur each year. HIV prevention research is crucial for groups at heightened risk for HIV, but the design and conduct of HIV prevention research with vulnerable populations worldwide raises considerable ethical challenges. The HIV Prevention Trials Network (HPTN) is a global collaborative network that conducts clinical and behavioural studies on non-vaccine interventions to reduce the transmission of HIV. In 2003, the HPTN developed ethical (...)
    Direct download (7 more)  
     
    My bibliography  
     
    Export citation  
  9. Jeremy Sugarman (2010). Reflections on Governance Models for the Clinical Translation of Stem Cells. Journal of Law, Medicine and Ethics 38 (2):251-256.
    Governance models for the oversight of human embryonic stem cell research have been proposed which mirror in large part familiar oversight mechanisms for research with human subjects and non-human animals. While such models are in principle readily endorsable, there are a set of concerns related to their implementation — such as ensuring that an elaborated informed consent process and conducting long-term monitoring of research subjects are tenable — which suggest areas where gathering data may facilitate more appropriate oversight. In addition, (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  10. Nancy E. Kass, Jeremy Sugarman, Amy M. Medley, Linda A. Fogarty, Holly A. Taylor, Christopher K. Daugherty, Mark R. Emerson, Steven N. Goodman, Fay J. Hlubocky & Herbert I. Hurwitz (2009). An Intervention to Improve Cancer Patients' Understanding of Early-Phase Clinical Trials. Irb 31 (3):1.
    No categories
    Direct download  
     
    My bibliography  
     
    Export citation  
  11. Jeremy Sugarman, Nancy Kass & Ruth Faden (2009). Categorizing Empirical Research in Bioethics: Why Count the Ways? American Journal of Bioethics 9 (6):66-67.
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  12. Matthew J. Czarny, Ruth R. Faden, Marie T. Nolan, Edwin Bodensiek & Jeremy Sugarman (2008). Medical and Nursing Students' Television Viewing Habits: Potential Implications for Bioethics. American Journal of Bioethics 8 (12):1 – 8.
    Television medical dramas frequently depict the practice of medicine and bioethical issues in a strikingly realistic but sometimes inaccurate fashion. Because these shows depict medicine so vividly and are so relevant to the career interests of medical and nursing students, they may affect these students' beliefs, attitudes, and perceptions regarding the practice of medicine and bioethical issues. We conducted a web-based survey of medical and nursing students to determine the medical drama viewing habits and impressions of bioethical issues depicted in (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  13. Matthew Czarny, Ruth Faden, Marie Nolan, Edwin Bodensiek & Jeremy Sugarman (2008). Response to Open Peer Commentaries on “Medical and Nursing Students' Television Viewing Habits: Potential Implications for Bioethics”. American Journal of Bioethics 8 (12):1-1.
    Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  14. Sara Chandros Hull, Richard Sharp, Jeffrey Botkin, Mark Brown, Mark Hughes, Jeremy Sugarman, Debra Schwinn, Pamela Sankar, Dragana Bolcic-Jankovic, Brian Clarridge & Benjamin Wilfond (2008). Patients' Views on Identifiability of Samples and Informed Consent for Genetic Research. American Journal of Bioethics 8 (10):62-70.
    Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  15. Neal Dickert & Jeremy Sugarman (2007). Getting the Ethics Right Regarding Research in the Emergency Setting: Lessons From the Polyheme Study. Kennedy Institute of Ethics Journal 17 (2):153-169.
    : Research in emergency settings (RES) has become a major public issue with urgent policy implications. Significant attention has focused recently on RES in response to the trial of PolyHeme, a synthetic blood substitute, in trauma victims in hemorrhagic shock. Unfortunately, the discussion of the PolyHeme trial in the popular and scholarly press leaves important questions unanswered. This paper articulates three important lessons from the PolyHeme trial that have significant policy implications. First, the RES regulations should be re-visited, particularly the (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  16. Rebecca D. Pentz, Anne L. Flamm, Jeremy Sugarman, Marlene Z. Cohen, Zhiheng Xu, Roy S. Herbst & James L. Abbruzzese (2007). Who Should Go First in Trials with Scarce Agents? The Views of Potential Participants. Irb: Ethics and Human Research 29 (4):1.
    No categories
    Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  17. Jeremy Sugarman (2007). Examining the Provisions for Research Without Consent in the Emergency Setting. Hastings Center Report 37 (1):12-13.
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  18. Jeremy Sugarman (2007). Roles of Moral Philosophy in Appropriated Bioethics: A Response to Baker and McCullough. Kennedy Institute of Ethics Journal 17 (1):65-67.
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  19. Neal W. Dickert & Jeremy Sugarman (2006). Community Consultation: Not the Problem - an Important Part of the Solution. American Journal of Bioethics 6 (3):26 – 28.
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  20. Kevin P. Weinfurt, Joëlle Y. Friedman, Michaela A. Dinan, Jennifer S. Allsbrook, Mark A. Hall, Jatinder K. Dhillon & Jeremy Sugarman (2006). Disclosing Conflicts of Interest in Clinical Research: Views of Institutional Review Boards, Conflict of Interest Committees, and Investigators. Journal of Law, Medicine Ethics 34 (3):581-591.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  21. Jeremy Sugarman (2005). Should the Gold Rule? Assessing "Equivalent Protections" for Research Participants Across International Borders. Hastings Center Report 35 (5):12-13.
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  22. Ruth W. Grant & Jeremy Sugarman (2004). Ethics in Human Subjects Research: Do Incentives Matter? Journal of Medicine and Philosophy 29 (6):717 – 738.
    There is considerable confusion regarding the ethical appropriateness of using incentives in research with human subjects. Previous work on determining whether incentives are unethical considers them as a form of undue influence or coercive offer. We understand the ethical issue of undue influence as an issue, not of coercion, but of corruption of judgment. By doing so we find that, for the most part, the use of incentives to recruit and retain research subjects is innocuous. But there are some instances (...)
    Direct download (12 more)  
     
    My bibliography  
     
    Export citation  
  23. Carol Levine, Ruth Faden, Christine Grady, Dale Hammerschmidt, Lisa Eckenwiler & Jeremy Sugarman (2004). A Response to Commentators on “The Limitations of 'Vulnerability' as a Protection for Human Research Participants”. American Journal of Bioethics 4 (3):W32-W32.
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  24. Carol Levine, Ruth Faden, Christine Grady, Dale Hammerschmidt, Lisa Eckenwiler & Jeremy Sugarman (2004). The Limitations of "Vulnerability" as a Protection for Human Research Participants. American Journal of Bioethics 4 (3):44 – 49.
    Vulnerability is one of the least examined concepts in research ethics. Vulnerability was linked in the Belmont Report to questions of justice in the selection of subjects. Regulations and policy documents regarding the ethical conduct of research have focused on vulnerability in terms of limitations of the capacity to provide informed consent. Other interpretations of vulnerability have emphasized unequal power relationships between politically and economically disadvantaged groups and investigators or sponsors. So many groups are now considered to be vulnerable in (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  25. Jeremy Sugarman (2004). Pausing to Consider Recommendations for Recasting the Professionalism Movement in Academic Medicine. American Journal of Bioethics 4 (2):16 – 17.
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  26. Jeremy Sugarman (2004). The Future of Empirical Research in Bioethics. Journal of Law, Medicine and Ethics 32 (2):226-231.
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  27. Jeremy Sugarman (2004). Using Empirical Data to Inform the Ethical Evaluation of Placebo Controlled Trials. Science and Engineering Ethics 10 (1):29-35.
    There has been considerable debate about the ethical acceptability of using placebo-controls in clinical research. Although this debate has been rich in rhetoric, considering that much of this research is predicated upon the assumption that data from this research is vital to clinical decision-making, it is ironic that researchers have introduced little data into these discussions. Using some published research concerning the use of placebo-controls in clinical research in hypertension and psychiatric drug trials, I suggest some ways that such data (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  28. Gavin W. Hougham, Greg A. Sachs, Deborah Danner, Jim Mintz, Marian Patterson, Laura W. Roberts, Laura A. Siminoff, Jeremy Sugarman, Peter J. Whitehouse & Donna Wirshing (2003). Empirical Research on Informed Consent with the Cognitively Impaired. Irb 25 (5):s26 - 32.
    No categories
    Direct download  
     
    My bibliography  
     
    Export citation  
  29. Kathleen M. MacQueen & Jeremy Sugarman (2003). Back to the Rough Ground: Working in International HIV Prevention as Ethical Debates Continue. Irb 25 (2):11-13.
    No categories
    Direct download  
     
    My bibliography  
     
    Export citation  
  30. Jeremy Sugarman (2003). Informed Consent, Shared Decision-Making, and Complementary and Alternative Medicine. Journal of Law, Medicine and Ethics 31 (2):247-250.
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  31. Baruch Brody, Nancy Dubler, Jeff Blustein, Arthur Caplan, Jeffrey P. Kahn, Nancy Kass, Bernard Lo, Jonathan Moreno, Jeremy Sugarman & Laurie Zoloth (2002). The Task Force Responds. Hastings Center Report 32 (3):22-23.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  32. Jeremy Sugarman, Lisa A. Eckenwiler & Ezekiel J. Emanuel (2002). Research Oversight Through New Lenses: The Consortium to Examine Clinical Research Ethics. Irb 25 (1):9-10.
    No categories
    Direct download  
     
    My bibliography  
     
    Export citation  
  33. Jeremy Sugarman (2001). Narrative Matters. American Journal of Bioethics 1 (1):46-46.
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  34. Jeremy Sugarman (2001). Taking a Hard Look at Advocacy in Research. Hastings Center Report 31 (6):47-48.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  35. Jeremy Sugarman, Douglas C. McCrory, Donald Powell, Alex Krasny, Betsy Adams, Eric Ball & Cynthia Cassell (1999). Empirical Research on Informed Consent: An Annotated Bibliography. Hastings Center Report 29 (1):1-42.
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  36. Valery M. Cordon, Jeremy Sugarman & Nancy Kass (1998). Toward a More Comprehensive Approach to Protecting Human Subjects. Irb 20.
    No categories
     
    My bibliography  
     
    Export citation  
  37. Nancy E. Kass & Jeremy Sugarman (1996). Are Research Subjects Adequately Protected? A Review and Discussion of Studies Conducted by the Advisory Committee on Human Radiation Experiments. Kennedy Institute of Ethics Journal 6 (3):271-282.
    : In light of information uncovered about human radiation experiments conducted during the Cold War, an important charge for the Advisory Committee on Human Radiation Experiments was to assess the current state of protections for human research subjects. This assessment was designed to enhance the Committee's ability to make informed recommendations for the improvement of future policies and practices for the protection of research subjects. The Committee's examination of current protections revealed great improvement over those from the past, yet some (...)
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  38. Nancy E. Kass, Jeremy Sugarman, Ruth Faden & Monica Schoch‐Spana (1996). Trust The Fragile Foundation of Contemporary Biomedical Research. Hastings Center Report 26 (5):25-29.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  39. Jeremy Sugarman (1996). Talking About Futility. Hastings Center Report 26 (3):41-41.
    Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  40. Jeremy Sugarman & Nancy E. Kass (1996). Are Research Subjects Adequately Protected? A Review and Discussion of Studies Conducted by the Advisory Committee on Human Radiation Experiments. Kennedy Institute of Ethics Journal 6 (3):271-282.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  41. Loane Skene, Jeremy Sugarman, Nancy E. Kass, Nadine Taub & Marion Danis (1994). Request From a Middle Eastern Bride. Cambridge Quarterly of Healthcare Ethics 3 (03):422-.
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  42. Jeremy Sugarman (1994). Outcomes Research and Advance Directives. Journal of Clinical Ethics 5 (1):60.
    No categories
    Direct download  
     
    My bibliography  
     
    Export citation  
  43. Jeremy Sugarman (1994). Recognizing Good Decisionmaking for Incapacitated Patients. Hastings Center Report 24 (6):11-13.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  44. Jeremy Sugarman, Nancy E. Kass, Ruth R. Faden & Steven N. Goodman (1994). Catalysts for Conversations About Advance Directives: The Influence of Physician And Patient Characteristics. Journal of Law, Medicine and Ethics 22 (1):29-35.
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  45. Jeremy Sugarman, Neil R. Powe, Dorothy A. Brillantes & Melanie K. Smith (1993). The Cost of Ethics Legislation: A Look at the Patient Self-Determination Act. Kennedy Institute of Ethics Journal 3 (4):387-399.
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation